Medtronic: Navigating Tariffs And Chinese VBP Challenges
Source: SeekingAlpha
2026-02-13 09:00:00 ET
Previous Coverage
In late July last year I covered Medtronic ( MDT ) following their Q4 earnings release. In that write-up I discussed the company's stagnant results, strong dividend history, and decent quarterly results. At that time, the stock appeared to be trading for a small discount and as such I rated the stock a HOLD as I want to see what future quarters would bring. Since my initial article, the stock has performed quite well, outpacing the broad market, as measured by ( SPY ) by more than 3.5%....
Read the full article on Seeking Alpha
For further details see:
Medtronic: Navigating Tariffs And Chinese VBP Challenges
Medtronic plc.
NASDAQ: MDT
MDT Trading
-0.18% G/L:
$87.64 Last:
2,931,069 Volume:
$87.66 Open:
MDT Latest News
March 12, 2026 08:17:40 am
Orchestra BioMed Reports Full Year 2025 Financial Results and Provides Fourth Quarter Business Update
March 10, 2026 06:45:00 am
Medtronic to acquire Scientia Vascular, marrying access and therapeutic portfolios for neurovascular care
MDT Stock Data
$130,938,521,134
1,269,194,066
0.03%
8
N/A
Medical Equipment & Supplies
Healthcare
IE
Galway
